[Sustained virologic response in patients with hepatitis C and chronic kidney disease].

Background: Patients with chronic kidney disease (CKD) have a higher prevalence of hepatitis C virus (HCV) infection compared to the general population, and they also present higher morbidity and mortality if they are not treated. Current treatment is based on different direct-acting antiviral (DAA) schemes, which are available in the Mexican health system. However, the efficacy and safety of DAA treatment in patients with CKD on hemodialysis and HCV infection are unknown in Mexican population.

[Factors associated with residual symptom burden in patients with peritoneal dialysis: a cohort study].

Background: Patients on peritoneal dialysis have residual symptoms that reduce their quality of life.

Objective: To determine the associated factors of residual symptom burden in patients with continuous ambulatory peritoneal dialysis (CAPD).

Material And Mehotds: An observational, longitudinal, prospective and analytical study was carried out in patients with chronic kidney disease, who were candidates for peritoneal dialysis.